Total Debt for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported total debt is $1.00B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingTotal DebtSwitch metric
Latest period
$1.00B
YoY change
-2.5%
5Y CAGR
-8.1%
Peak year (2023)
$1.58B
Latest annual
$851.81M
Total Debt history chart for ResMed (RMD) from 1993 to 2025
Total Debt history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $851.81M | -2.5% | ||
| 2024 | $873.93M | -44.7% | ||
| 2023 | $1.58B | +72.2% | ||
| 2022 | $917.55M | +15.6% | ||
| 2021 | $793.72M | -38.9% | ||
| 2020 | $1.30B | +2.2% | ||
| 2019 | $1.27B | +351.5% | ||
| 2018 | $281.45M | -73.9% | ||
| 2017 | $1.08B | -8.0% | ||
| 2016 | $1.17B | +290.2% | ||
| 2015 | $300.59M | -0.1% | ||
| 2014 | $300.79M | +0.0% | ||
| 2013 | $300.79M | +19.9% | ||
| 2012 | $250.84M | +150.4% | ||
| 2011 | $100.16M | -17.7% | ||
| 2010 | $121.69M | -24.8% | ||
| 2009 | $161.74M | +17.5% | ||
| 2008 | $137.65M | +18.7% | ||
| 2007 | $116.00M | -4.2% | ||
| 2006 | $121.08M | -30.6% | ||
| 2005 | $174.37M | +54.0% | ||
| 2004 | $113.25M | 0.0% | ||
| 2003 | $113.25M | -8.1% | ||
| 2002 | $123.25M | -17.8% | ||
| 2001 | $150.00M | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | -100.0% | ||
| 1998 | $200,000 | -66.7% | ||
| 1997 | $600,000 | -33.3% | ||
| 1996 | $900,000 | +12.5% | ||
| 1995 | $800,000 | +100.0% | ||
| 1994 | $400,000 | +33.3% | ||
| 1993 | $300,000 | — |
Total Debt values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual total debt for ResMed (RMD) came in at $851.81M – edged down 2.5% year-over-year.
Across 2020–2025 (5 years), ResMed total debt produced a CAGR of -8.1% – with a net decline across the window.
The dataset's maximum total debt sits at $1.58B (2023); the minimum reading of $0 dates to 1999.
Among 8 Healthcare peers, ResMed (RMD) ranks 9th; the peer median for total debt is $52.57B.
ResMed Total Debt by Year
ResMed Total Debt 2025: $851.81M
ResMed total debt in 2025 was $851.81M, edged down 2.5% below 2024.
ResMed Total Debt 2024: $873.93M
ResMed total debt in 2024 was $873.93M, plunged 44.7% below 2023.
ResMed Total Debt 2023: $1.58B
ResMed total debt in 2023 was $1.58B, surged 72.2% from 2022. This figure represents the highest annual value in the available history.
ResMed Total Debt 2022: $917.55M
ResMed total debt in 2022 was $917.55M, grew 15.6% from 2021.
ResMed Total Debt 2021: $793.72M
ResMed total debt in 2021 was $793.72M.
See more financial history for ResMed (RMD).
Sector peers — Total Debt
Companies in the same sector as ResMed, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is ResMed's total debt?
- Latest reported total debt for ResMed (RMD) is $1.00B (period ending December 31, 2025).
How has ResMed total debt changed year-over-year?
- ResMed (RMD) total debt changed -2.5% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed total debt?
- ResMed (RMD) total debt compound annual growth rate is -8.1% over the most recent 5 years available.
When did ResMed total debt hit its highest annual value?
- ResMed total debt reached its highest annual value of $1.58B in 2023.
What was ResMed total debt in 2024?
- ResMed (RMD) total debt in 2024 was $873.93M.
What was ResMed total debt in 2025?
- ResMed (RMD) total debt in 2025 was $851.81M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.